Vivo Infusion, a nationally recognized provider of accessible and affordable ambulatory infusion services, announced it has acquired the Neurology Institute of San Antonio (NISA) and Vista Infusions, an industry leader in ambulatory infusion services and a leading neurological center of excellence. And with this acquisition, Vivo Infusion will manage nearly 90 ambulatory infusion centers across 15 states. The financial terms of the transaction were not disclosed.
Launched in 2003, the company offers outstanding patient care to the local community and has grown in the greater San Antonio market through de novo center openings. And the company is a leader as the infusion provider of choice for patients suffering from multiple sclerosis and other neurological conditions. Following the transaction, Vivo will have 20 locations across Texas, including infusion centers in Dallas, Houston, Longview, Tyler, and San Antonio.
Dr. Gazda and Dr. Braden Neiman will continue practicing as neurologists with Vivo's assistance in growth initiatives.
Fifth Third Securities was the exclusive financial advisor to NISA and Vista Infusions for this transaction.
KEY QUOTES:
"We are thrilled to continue to build on the reputation of NISA and Vista Infusions and welcome them into the Vivo family. NISA and Vista continue Vivo's emphasis as an infusion provider of choice for neurological and autoimmune diseases. We believe that by partnering with leading physician practices like that of Drs. Gazda and Neiman, we can advance the quality of care for patients while improving value. We are delighted to join forces with Drs. Gazda, Neiman, and the entire NISA and Vista teams."
- Steve Rodgers, Chief Executive Officer of Vivo Infusion